1. Home
  2. BFAM vs RCUS Comparison

BFAM vs RCUS Comparison

Compare BFAM & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Horizons Family Solutions Inc.

BFAM

Bright Horizons Family Solutions Inc.

HOLD

Current Price

$75.14

Market Cap

3.6B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$30.33

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFAM
RCUS
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.8B
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
BFAM
RCUS
Price
$75.14
$30.33
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$114.57
$31.90
AVG Volume (30 Days)
1.0M
1.6M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
40.00
N/A
EPS
0.62
N/A
Revenue
$1,903,182,000.00
$247,000,000.00
Revenue This Year
$8.19
N/A
Revenue Next Year
$5.83
$45.62
P/E Ratio
$121.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.63
$8.03
52 Week High
$130.76
$31.74

Technical Indicators

Market Signals
Indicator
BFAM
RCUS
Relative Strength Index (RSI) 68.73 65.68
Support Level $74.89 $19.78
Resistance Level $79.38 N/A
Average True Range (ATR) 2.13 1.61
MACD 1.48 0.48
Stochastic Oscillator 99.51 83.40

Price Performance

Historical Comparison
BFAM
RCUS

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; Full-service center-based child care, Backup care, and Educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: